Retraction appears for former federal contractor who faked data

cebpIn December, we reported on the case of Timothy Sheehy, a former government contractor who was found to have faked results. ORI found that Sheehy

fabricated the quantitative and qualitative data for RNA and DNA purportedly extracted from 900 formalin-fixed, paraffin-embedded (FFPE) colorectal tissue samples presented in Table 1 of the CEBP paper and falsely reported successful methodology to simultaneously recover nucleic acids from FFPE tissue specimens, when neither the extractions nor analyses of the FFPE samples were done. Thus, the main conclusions of the CEBP paper are based on fabricated data and are false.

Sheehy agreed to ask that one of his papers be retracted. The retraction notice has appeared: Continue reading Retraction appears for former federal contractor who faked data

New Dutch psychology scandal? Inquiry cites data manipulation, calls for retraction

sppsThe University of Amsterdam has called for the retraction of a 2011 paper by two psychology researchers after a school investigation concluded that the article contained bogus data, the Dutch press are reporting.

The paper, “Sense Creative! The Impact of Global and Local Vision, Hearing, Touching, Tasting and Smelling on Creative and Analytic Thought,” was written by Jens Förster and Markus Denzler  and published in Social Psychological & Personality Science. It purported to find that:

Continue reading New Dutch psychology scandal? Inquiry cites data manipulation, calls for retraction

Former Mount Sinai postdoc faked gene therapy data: ORI

ori logoA former postdoc at the Mount Sinai School of Medicine in New York faked data in four published papers, one submitted manuscript, and four NIH grant applications, according to new findings by the Office of Research Integrity.

We reported on six retractions from Savio Woo’s Mount Sinai lab in 2010, from the Proceedings of the National Academy of Sciences (PNAS), the Journal of the National Cancer Institute, and two each from Human Gene Therapy and Molecular Therapy. The PNAS paper, as we noted then:

claimed to have discovered a possible cure for phenylketonuria, or PKU, in mice—a finding that was cited more than 30 times and trumpeted in the media.

At the time, Mount Sinai said that two of the lab’s postdocs had been dismissed for misconduct. Now, more than three and a half years later, the ORI reports that a former postdoc in that lab, Li Chen: Continue reading Former Mount Sinai postdoc faked gene therapy data: ORI

Scientist found to have falsified data in thesis sues to keep her PhD

org lettersIn August 2012, the authors of “Novel Approach to the Lundurine Alkaloids: Synthesis of the Tetracyclic Core,” a paper in Organic Letters, retracted it:

The authors retract this Organic Letters communication on the basis that the RCM of 24 to give 25 (Scheme 6) is not reproducible; thus, the reduction of 25 to give 26 (Scheme 7) is also not reproducible.

The case was covered in some detail by The Heterocyclist blog, and also by Derek Lowe at In The Pipeline, who called it “an odd retraction.” Lowe recently picked up the story with an update: The first author, Suvi Orr, is suing the University of Texas-Austin, where she earned her PhD and did the work, to stop them from taking away her degree.

The Austin American-Statesman reported last month: Continue reading Scientist found to have falsified data in thesis sues to keep her PhD

NIH/Harvard team loses aging study to manipulated data

agecoverAge has retracted a 2012 article by a group of scientists from the National Institutes of Health and Brigham and Women’s Hospital in Boston after an NIH inquiry turned up evidence of data manipulation in the work.

The article, “Aging decreases rate of docosahexaenoic acid synthesis-secretion from circulating unesterified α-linolenic acid by rat liver,” came from the lab of Stanley Rapoport, chief of the brain physiology and metabolism section of the National Institute on Aging.

As the abstract explained: Continue reading NIH/Harvard team loses aging study to manipulated data

Retraction four appears for Dirk Smeesters

smeestersDirk Smeesters, the former psychology professor at Erasmus University found to have committed misconduct, has had another paper retracted.

Here’s the notice: Continue reading Retraction four appears for Dirk Smeesters

First retraction appears for Dutch anthropologist Mart Bax

ethnicracstudLast September we wrote about the case of Mart Bax, an anthropologist once of the Free University in Amsterdam who allegedly fabricated elements in some of his papers, and claimed to have written more than 60 that do not exist:

Bax, who studied an Irish town he called Patricksville, a Dutch pilgrimage site he called Neerdonk, and Medjugorje, a Bosnian pilgrimage site, retired from the Free University in 2002. The university began investigating Bax’s work last year after science journalist Frank van Kolfschooten published Ontspoorde Wetenschap (“Derailed science”). In that book, van Kolfschooten raised questions about Bax’s work into an alleged massacre at Medjugorje during the Bosnian War. Bax responded to those questions in April of this year.

Here’s the university’s 67-page report, in Dutch. The university will not take legal action against Bax. It is unclear from the translations we’ve seen whether any of the papers will be retracted, but we’ll update with anything we learn.

Well, at least part of that ambiguity has cleared, with the retraction of a 2000 paper by Bax in Ethnic and Racial Studies. The article was titled “Warlords, priests and the politics of ethnic cleansing: a case-study from rural Bosnia Hercegovina” and has been cited 20 times, according to Thomson Scientific’s Web of Knowledge. Here’s its abstract: Continue reading First retraction appears for Dutch anthropologist Mart Bax

Novartis Diovan scandal claims two more papers

diabetes careA complicated story involving Novartis’s valsartan (Diovan) has led to the retraction of two more papers, one cascading from the other.

Last September, The Lancet retracted the Jikei Heart Study after a slew of retractions of related work prompted an investigation of valsartan research. That investigation found evidence of data manipulation and the failure of one researcher to note his Novartis affiliation. The company has apologized.

Here’s one retraction, from Diabetes Care, for “The Shiga Microalbuminuria Reduction Trial (SMART) Group. Reduction of Microalbuminuria in Patients With Type 2 Diabetes: The Shiga Microalbuminuria Reduction Trial (SMART):”

Continue reading Novartis Diovan scandal claims two more papers